Saturday, December 6, 2025

Tech Giants Unite in Seoul to Kick Off the New Era of AI Governance

Fourteen South Korean and international AI companies...

North Korean Immigration to Russia Hits 13,000 in 2024, Driven by Education and Business

North Korean visits to Russia surged to 13,221 in 2024, raising concerns about disguised labor under educational visas.

North Korea’s Ruling Party Tells Citizens: Work Harder, October Is Coming

North Korea emphasizes economic achievements ahead of the Workers' Party anniversary, urging mobilization in various sectors while criticizing Israel.

Health

The Easiest Way To Lose Investor Trust? Just Steal $6.7 Billion! BMS Masterclass In Bad Business

Bristol Myers Squibb faces a $6.7B lawsuit over alleged delays in drug approvals affecting former Celgene shareholders' payouts.

Global Pharma Giants Join Samsung Biologics in Major Climate Pledge to Cut Supply-Chain Emissions by 2030

Samsung Biologics leads a global initiative to reduce carbon emissions in healthcare, aiming for sustainability and renewable energy by 2030.

TRUST ME, I’m an Expert: Trump’s Tylenol-Autism Claim Exposes Washington’s Dangerous NEW Brand of Idiocy

Trump claims Tylenol during pregnancy may raise autism risk, but medical experts refute this as unsupported by scientific evidence.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.
Latest

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

The Hidden Code: How RNA Editing Could Hold the Key to Parkinson’s

Korean researchers discovered that RNA editing plays a crucial role in regulating neuroinflammation in Parkinson's disease.

Misdiagnosed for Years: Ankylosing Spondylitis Cases Rise 1.5 Times Over a Decade

Ankylosing spondylitis is a chronic arthritis affecting young men, causing severe spinal pain and stiffness, requiring early diagnosis.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

Your Gums Hurt but No Cavities? It Might Be Something Worse

Over 75% of adults suffer from periodontal disease, which can lead to tooth loss. Early detection and proper care are crucial for prevention.

Herpes and the Brain: Could a Common STI Be Fueling the Dementia Crisis?

A study reveals men with genital herpes (HSV-2) face over double the dementia risk, highlighting the need for awareness and research.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

The Cells That Start It All: KAIST Breaks Ground in Brain Cancer Research

Researchers at KAIST have identified precancerous cells in glioblastoma, revealing their role in tumor evolution and treatment resistance.

Teen Guys with ‘Man Boobs’ Are Turning to Surgery—Here’s Why

A 19-year-old struggles with gynecomastia, seeking surgery. The condition causes social distress and requires careful evaluation.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

GIST Team Develops Real-Time Blood Flow Sensor with Dual Hydration Modeling

A South Korean team developed a technology for real-time genetic analysis of blood components, enhancing blood test accuracy significantly.

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.